B-190 (B-190)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

Active substance:

B-190 150 mg

Excipients:
silicon dioxide colloid (aerosil) - 2.0 mg; potato starch 5.0 mg; magnesium stearate - 2.0 mg; cellulose microcrystalline - 33.0 mg; povidone 4.0 mg; talcum - 4.0 mg.
Pharmacotherapeutic group:Alpha-adrenomimetic
ATX: & nbsp
  • Adreno- and dopaminomimetics
    • Pregnancy and lactation:During pregnancy and during breastfeeding, the use of the drug is contraindicated.
    Interaction:

    Information about the adverse effects of the drug on the ability to manage vehicles and mechanisms are not available.

    Possible adverse reactions from the cardiovascular system in the form of atrioventricular dissociation and atrioventricular blockade. This should be taken into account when carrying out the above actions.

    Form release / dosage:Tablets 150 mg.
    Packaging:

    By 3, 6 or 10 tablets in a planar cell packaging from a polyvinyl chloride film and aluminum foil.

    Contour-cell packaging without a secondary (consumer) package for 3, 6 or 10 tablets is intended for special purposes.

    1 circuit cell pack of 3 or 10 tablets together with instructions for use in a pack of cardboard.

    Storage conditions:

    In a dry, protected from light place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    The drug should not be used after the expiry date indicated on the package.

    Terms of leave from pharmacies:For hospitals
    Registration number:P N002437 / 02
    Date of registration:07.06.2008 / 14.08.2014
    Expiration Date:Unlimited
    The owner of the registration certificate:FARMZASCHITA NPC, FSUE FARMZASCHITA NPC, FSUE Russia
    Manufacturer: & nbsp
    Information update date: & nbsp11.01.17
    Illustrated instructions
      Instructions
      Up